GloMax(R) Discover System and Dual Injectors with Pumps
Closed Special Notice Posted
- Solicitation number
- NOI-CC-OLAO-26-007847
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Health Clinical Center issued a Notice of Intent on July 8, 2026 to negotiate a sole-source acquisition with Promega Corporation for the GloMax Discover System and Dual Injectors with Pumps, with a deadline of July 23, 2026 for capability statement submissions.
The procurement supports time-sensitive research investigations central to the Clinical Center and NIH missions; the agency asserts that failure to procure from the sole source would jeopardize experiments and waste previously invested funds. The statutory authority cited is 41 U.S.C. 253(c)(1), implemented under FAR 6.302-1 (only one responsible source and no other supply or service will satisfy requirements).
This is not a request for proposal. All responsible sources capable of providing the required equipment may submit a capability statement by email to valerie.gregorio@nih.gov with subject line NOI-CC-OLAO-26-007847 by 12:00 PM Eastern on July 23, 2026. The Government will consider all responses received by the closing date, though the determination to proceed with or without competition remains solely within the Government's discretion.
NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing); PSC 6640 (Laboratory Equipment and Supplies).
Notice text
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Promega Corporation.
Acquisition Description:
Order is associated with research investigations that are central to the mission of the Clinical Center and the NIH. Failure to fulfill would jeopardize time-sensitive experiments & would waste already-invested funds.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-007847) by 12:00 PM eastern standard time on 07/23/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity